BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37299000)

  • 21. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway.
    Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG
    Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
    Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
    BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells.
    Adler D; Langer B; Lindstrot A; Florin A; Bosserhoff A; Buettner R; Wernert N
    Oncol Rep; 2011 Apr; 25(4):1125-9. PubMed ID: 21258770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
    Fu YM; Yu ZX; Li YQ; Ge X; Sanchez PJ; Fu X; Meadows GG
    Nutr Cancer; 2003; 45(1):60-73. PubMed ID: 12791506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maclurin exerts anti-cancer effects on PC3 human prostate cancer cells via activation of p38 and inhibitions of JNK, FAK, AKT, and c-Myc signaling pathways.
    Lee YJ; Jung O; Lee J; Son J; Cho JY; Ryou C; Lee SY
    Nutr Res; 2018 Oct; 58():62-71. PubMed ID: 30340816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEK4 function, genistein treatment, and invasion of human prostate cancer cells.
    Xu L; Ding Y; Catalona WJ; Yang XJ; Anderson WF; Jovanovic B; Wellman K; Killmer J; Huang X; Scheidt KA; Montgomery RB; Bergan RC
    J Natl Cancer Inst; 2009 Aug; 101(16):1141-55. PubMed ID: 19638505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNase L is a negative regulator of cell migration.
    Banerjee S; Li G; Li Y; Gaughan C; Baskar D; Parker Y; Lindner DJ; Weiss SR; Silverman RH
    Oncotarget; 2015 Dec; 6(42):44360-72. PubMed ID: 26517238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
    Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
    Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
    Roberto D; Klotz LH; Venkateswaran V
    Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-κB signaling in LPS-induced PC3 cells.
    Ogut D; Reel B; Gonen Korkmaz C; Arun MZ; Cilaker Micili S; Ergur BU
    Folia Histochem Cytobiol; 2016; 54(4):171-180. PubMed ID: 27966209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Knockdown of mediator complex subunit 19 suppresses the migration and invasion and epithelial-mesenchymal transition in prostate cancer PC3 cells].
    Zhang YL; Wang P; Zhang Y; Yu SS; Xu YK
    Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(42):3303-3307. PubMed ID: 31715665
    [No Abstract]   [Full Text] [Related]  

  • 33. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.
    Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE
    Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.
    Uygur B; Wu WS
    Mol Cancer; 2011 Nov; 10():139. PubMed ID: 22074556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on effect and mechanism of Huaier aqueous extract on growth and invasion of human prostate cancer PC3 cells].
    Yang AL; Hu ZD; Tu PF
    Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(14):2701-2705. PubMed ID: 28905609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal adhesion kinase signaling is necessary for the Cyclosporin A-enhanced migration and invasion of human trophoblast cells.
    Tang CL; Zhao HB; Li MQ; Du MR; Meng YH; Li DJ
    Placenta; 2012 Sep; 33(9):704-11. PubMed ID: 22766276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of miR-145 on the migration and invasion of prostate cancer PC3 cells by targeting DAB2].
    Xie S; Xie Y; Zhang Y; Huang Q
    Yi Chuan; 2014 Jan; 36(1):50-7. PubMed ID: 24846918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation of expression of RhoC with invasiveness of prostate cancer cell line PC-3M in vitro].
    Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):51-5. PubMed ID: 18346381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression.
    Chen PS; Shih YW; Huang HC; Cheng HW
    PLoS One; 2011; 6(5):e20164. PubMed ID: 21629786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.